Emicizumab
Product Description
Hangzhou Jiuyuan Genetic Biopharmaceutic
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:5
-
Employees:1000 - 4999
Company types
Categories
Specifications
Hangzhou Jiuyuan Genetic Biopharmaceutic
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:5
-
Employees:1000 - 4999
Company types
More Products from Hangzhou Jiuyuan Genetic Biopharmaceutic (18)
-
Product Amylin analog
Weight management -
Product Avatrombopag maleate
thrombocytopeniaTablet: 20mg per tablet -
Product Bone repair material with rhBMP-2 - Bone repair
a new bone repair material， registered as an implanted medical device
-
Product Daratumumab
Multiple myeloma (CD-38 mab) -
Product Daratumumab (with recombinant human hyaluronidase)
Multiple myeloma -
Product Dulaglutide
diabetes (recombinant route) -
Product Enoxaparin Sodium
anticoagulant and antithrombotic, the most widely accepted LMWH by doctors
-
Product Fulvestrant
an anti-cancer drug, Bulk and injection (PFS): 250mg in 5ml
-
Product Palonosetron Hydrochloride
anti-emesis after chemotherapy or radio therapy Palonosetron, Aloxi,
Injection (ampoule): 0.25mg/5ml， 0.075mg/1.5ml
-
Product Palonosetron Hydrochloride
anti-emesis after chemotherapy or radiotherapy, Active pharmaceutical ingredient (API) , Injection (ampoule): 0.25mg/5ml
-
Product Pegfilgrastim
long lasting filgrastim, pegylated filgrastim, neulasta -
Product Recombinant Human Bone Morphogenetic Protein-2
rhBMP-2， a new bone repair material，registered as an implanted medical device， Active pharmaceutical ingredient (API)，Tablet (vial): 1mg/vial